[Current developments in fibrinolytic therapy].
D005342:Fibrinolysis / Q000187:drug effects*; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006023:Glycoproteins / Q000502:physiology; D006801:Humans; D010960:Plasminogen Activators / Q000037:antagonists & inhibitors; D015849:Plasminogen Inactivators; D010959:Tissue Plasminogen Activator / Q000378:metabolism / Q000627:therapeutic use; D000979:alpha-2-Antiplasmin / Q000494:pharmacology
D005343:Fibrinolytic Agents; D006023:Glycoproteins; D015849:Plasminogen Inactivators; D000979:alpha-2-Antiplasmin; D010960:Plasminogen Activators; D010959:Tissue Plasminogen Activator
Nieuwe ontwikkelingen in fibrinolytische therapie.